HSBC Maintains Reduce on Eli Lilly, Raises Price Target to $940

Benzinga Newsdesk www.benzinga.com Positive 75.9%

Neg 0% Neu 0% Pos 75.9%

HSBC analyst Rajesh Kumar maintains Eli Lilly (NYSE:LLY) with a Reduce and raises the price target from $850 to $940.

Comments

No comments yet. Be the first!